Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients.

Makoto HikiYoko TabeTomohiko AiYuya MatsueNorihiro HaradaKiichi SugimotoYasushi MatsushitaMasakazu MatsushitaMitsuru WakitaShigeki MisawaMayumi IdeiTakashi MiidaNaoto TamuraKazuhisa TakahashiToshio Naito

Published in: PloS one (2021)

A serologic anti-SARS-CoV-2 antibody analysis can complement PCR for diagnosing COVID-19 14 days after symptom onset.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
patient reported
data analysis